Enterprise master patient index

East Tennessee Health Information Network (etHIN) Solves Duplicate Records Problem with Help of 4medica

Retrieved on: 
Tuesday, September 12, 2023
Data management, EMPI, Enterprise master patient index, Record, Organization, Hospital, Patient, Patient safety, DEL, Black Book, Health, Roger Hawkins (drummer), Pharmaceutical industry, Nursing

MARINA DEL REY, Calif., Sept. 12, 2023 /PRNewswire/ -- 4medica®, a renowned healthcare data quality leader specializing in enterprise master person index (eMPI) matching technology and real-time interoperability, today announced that they have assisted the East Tennessee Health Information Network (etHIN) with their management of duplicate patient records.

Key Points: 
  • 4medica began work in December 2022 on etHIN's Enterprise Master Patient Index (eMPI), which comprised more than 6 million records and included 2.7 million total patient identities.
  • "etHIN's eMPI was typical of health information exchanges, with a large number of duplicate and overlaid records that can impact a participating organization's ability to access accurate and quality patient data," said Gregg Church, president of 4medica.
  • 4medica identified and met etHIN's targeted duplicate rate reduction of 0.39% or 7,411 unmatched identities, an excellent eMPI clean-up accomplishment.
  • It is common for health information exchanges to have duplicate patient records due to the data received from their data sources.

San Diego Health Connect Selects 4medica to Reduce Duplicate Patient Records

Retrieved on: 
Tuesday, August 15, 2023
EMPI, Enterprise master patient index, MPI, Record, Organization, Hospital, Patient, Patient safety, Serving His Children, DEL, Imperial County, California, Black Book, Health, Health insurance, Nursing

San Diego Health Connect securely connects hospitals, health systems, patients, private health information exchanges (HIEs) and other healthcare stakeholders so that they can share important health information.

Key Points: 
  • San Diego Health Connect securely connects hospitals, health systems, patients, private health information exchanges (HIEs) and other healthcare stakeholders so that they can share important health information.
  • 4medica will begin with a thorough assessment of San Diego Health Connect's health data quality, focusing on duplicate patient records.
  • "We're excited to work with San Diego Health Connect and its members to reduce duplicate records, improve health data quality and produce healthier outcomes for the individuals and communities the organization serves," said 4medica President Gregg Church.
  • "Accurate, reliable patient data is at the core of effective health care and we are committed to providing San Diego Health Connect with the best possible patient database."

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

Retrieved on: 
Tuesday, August 8, 2023
NRS, ACR, APG system, RA, Arthritis, Interleukin-1 family, Enterprise master patient index, Arthritis Foundation, Quality of life, American College of Rheumatology, Tenderness, Inflammation, Person, Rheumatoid arthritis, CDC, Pain, Joint, American College, Phase, CDAI, MTX, Safety, Pharmaceutical industry

AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.

Key Points: 
  • AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.
  • Natrunix blocks a key cause of inflammation involved in pain and joint destruction in rheumatoid arthritis (RA).
  • The primary endpoint of the Phase II is the American College of Rheumatology (ACR) 20% Response (ACR 20) rate at 12 weeks.
  • In addition, it is expected that 300,000 children will suffer from juvenile arthritis (Arthritis Foundation, 2023).

Redox Announces a Reimagined Product Portfolio to Deliver Composable Healthcare for Payers, Providers, and Digital Health Builders

Retrieved on: 
Thursday, April 27, 2023
Nexus, Maintenance, Professional services, Chroma, Agility, Health, Face, Workflow, EMPI, Enterprise master patient index, API, DICOM, ML, FHIR, Electronic health record, Representational state transfer, Organization, Health Level 7, Digital, AI, Library, Medical imaging, Redox

MADISON, Wis., April 26, 2023 /PRNewswire/ -- Redox , the leader in healthcare interoperability – connecting healthcare's products , providers, and payers, today unveiled its reimagined product portfolio.

Key Points: 
  • MADISON, Wis., April 26, 2023 /PRNewswire/ -- Redox , the leader in healthcare interoperability – connecting healthcare's products , providers, and payers, today unveiled its reimagined product portfolio.
  • These new products enable everyone from healthcare product teams, to EHRs, payers and providers to use a composable healthcare digital strategy to grow and adapt in the face of sustained market uncertainty.
  • "With our new product portfolio, we're able to deliver value with greater scale, speed, and flexibility."
  • Organizations who utilize Redox products are poised to respond with agility and to continue to grow despite these headwinds.

New Jersey Innovation Institute Achieves Centers for Medicare & Medicaid Services Certification for New Jersey Health Information Network

Retrieved on: 
Monday, March 27, 2023
Transfer, New Jersey Department of Health, Enterprise master patient index, Medicaid, CMS, Partnership, MES, Centers for Medicare & Medicaid Services, Human services, FQHC, Long-term care, Ministry of Women and Vulnerable Populations, Federally Qualified Health Center, ADT, HIT, Limit state design, Certification, HITRUST, Medicare, Organization, ACRS, Public Health Information Network, Patient, Serving His Children, New Jersey Department of Human Services, Admission, Health information exchange, Nursing

NEWARK, N.J., March 27, 2023 /PRNewswire-PRWeb/ -- New Jersey Innovation Institute (NJII), a leading provider of innovative and transformative services across the state, announced today that the New Jersey Department of Human Services (NJDHS) and New Jersey Health Information Network (NJHIN) have been granted Centers for Medicare & Medicaid Services (CMS) Medicaid Enterprise System (MES) certification. A long-standing facilitator of many statewide healthcare initiatives, NJDHS has been a key partner with NJHIN in driving interoperability across New Jersey and ensuring healthy outcomes for more than 2.2 million Medicaid beneficiaries. NJHIN is the State Designated Entity to advance interoperable Health Information Technology (HIT) services to support health information exchange and is the only network that facilitates the electronic exchange of protected health information across the entire state of New Jersey. This new certification is a testament to the long-standing vision and goals shared by NJDHS and NJHIN and will allow the organizations to continue their crucial roles in connecting patients and providers to critical healthcare data, enabling substance use disorder and long-term care facilities, and supporting New Jersey’s underserved populations through a variety of public health initiatives.

Key Points: 
  • NEWARK, N.J., March 27, 2023 /PRNewswire-PRWeb/ -- New Jersey Innovation Institute (NJII), a leading provider of innovative and transformative services across the state, announced today that the New Jersey Department of Human Services (NJDHS) and New Jersey Health Information Network (NJHIN) have been granted Centers for Medicare & Medicaid Services (CMS) Medicaid Enterprise System (MES) certification.
  • NJHIN is the State Designated Entity to advance interoperable Health Information Technology (HIT) services to support health information exchange and is the only network that facilitates the electronic exchange of protected health information across the entire state of New Jersey.
  • It enables NJII to draw down federal matching dollars to continue funding for the Health Information Network and ensure that services and operations continue.
  • Currently, all New Jersey hospitals, long-term care, assisted living and Federally Qualified Health Center (FQHC)s are connected and contributing to NJHIN.

Fujifilm’s Synapse® Vendor Neutral Archive (VNA) Ranks “Best in KLAS” for the Fourth Consecutive Year

Retrieved on: 
Wednesday, February 8, 2023
Health, Enterprise master patient index, Research, Radiology, Software, IDS, Mammography, VNA, Synapse, Cardiology, PACS, Medical imaging, Pharmaceutical industry, KLAS

“Congratulations to all the winning vendors for setting the bar for excellence in healthcare IT!

Key Points: 
  • “Congratulations to all the winning vendors for setting the bar for excellence in healthcare IT!
  • An industry first, Synapse 7x PACS combines radiology, cardiology, mammography and specialty department imaging through one diagnostic PACS viewer.
  • KLAS is an independent research organization that monitors and assesses healthcare vendor performance.
  • Click below to access Fujifilm’s 2023 Best in KLAS report segments for:

East Tennessee Health Information Network (etHIN) Selects 4medica to Reduce Duplicate Patient Records

Retrieved on: 
Wednesday, January 4, 2023
Radiology, Patient, Patient safety, Enterprise master patient index, Hi-MD, EMR, Health information exchange, RCM, Acos, Black Book, Laboratory, Data management, MPI, DEL, Hin Hua High School, Hospital, Record, Pharmaceutical industry, Medical imaging, Health insurance

MARINA DEL REY, Calif., Jan. 4, 2023 /PRNewswire/ -- 4medica®, a leader in healthcare data quality and matching technology, today announced that East Tennessee Health Information Network (etHIN) will deploy 4medica's cloud-based Data Quality Platform to improve patient matching and health data quality.

Key Points: 
  • MARINA DEL REY, Calif., Jan. 4, 2023 /PRNewswire/ -- 4medica®, a leader in healthcare data quality and matching technology, today announced that East Tennessee Health Information Network (etHIN) will deploy 4medica's cloud-based Data Quality Platform to improve patient matching and health data quality.
  • 4medica will begin by conducting a thorough assessment of etHIN's health data quality, focusing on duplicate patient records.
  • It's common for health information exchanges (HIEs) to have excessive duplicate patient records due to mistakes at registration and other points of data entry.
  • etHIN is a non-profit community health information network established in 2005 to serve the information needs of healthcare providers in Tennessee.

4medica's Healthcare Data Quality Platform Uses Artificial Intelligence and Machine Learning to Reduce Costly Patient Matching Errors

Retrieved on: 
Wednesday, August 10, 2022
Machine learning, EMPI, Multimedia, Laboratory, Enterprise master patient index, CEO, Health care, AI, Technology, Hospital, EMR, DEL, Radiology, Patient, General manager, Hi-MD, Acos, Automation, RCM, Artificial intelligence, Ban Hin Kiong Temple, Data management, Solution, MPI, Black Book, Organization, ML, Medical device, Medical imaging

MARINA DEL REY, Calif., Aug. 10, 2022 /PRNewswire/ -- 4medica, a leader in healthcare data quality and matching technology, today announced that its cloud-based Data Quality Platform now deploys artificial intelligence (AI) and machine learning (ML) to improve patient matching.

Key Points: 
  • MARINA DEL REY, Calif., Aug. 10, 2022 /PRNewswire/ -- 4medica, a leader in healthcare data quality and matching technology, today announced that its cloud-based Data Quality Platform now deploys artificial intelligence (AI) and machine learning (ML) to improve patient matching.
  • Utilizing the most technologically advanced Master Patient Index (MPI) process, 4medica has revolutionized how organizations can analyze, improve, and utilize health data.
  • Duplications and other patient matching errors not only can endanger patient safety, they result in costly inefficiencies (such as duplicate tests being ordered) and dilute the value of a healthcare organization's data.
  • Since 1998, 4medica has been solving challenges around health data quality, enabling healthcare organizations to achieve real-time clinical interoperability.

North America Master Patient Index Software Markets, 2021-2028: Digitalization of Healthcare Processes & Adoption of Cloud-Based Technologies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 29, 2022
Technology, Software, Cloud, Adoption, Risk, CAGR, Vaccination, Enterprise master patient index, Growth, Leukemia, Patient, Demography, Software, Health, Registry, Data collection, LLS, COVID-19, COVID19, Movement, Lymphatic system, Partnership, Medical device, Pharmaceutical industry, Service

Software Segment has the Largest Share of Type in the North America Master Patient Index Software Market during 2021-2028.

Key Points: 
  • Software Segment has the Largest Share of Type in the North America Master Patient Index Software Market during 2021-2028.
  • North America Master Patient Index Software Market is expected to reach US$ 738.5 million by 2028 from US$ 365.3 million in 2021 and is estimated to grow at a CAGR of 10.6% from 2021 to 2028.
  • The effectiveness of Master Patient index software to gather and analyze patient data is expected to have a constructive impact on the adoption of Master Patient index software in the region.
  • The exchange of the medical record of the patients is being done through the master patient index software.

Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar® Gel (Repository Corticotropin Injection) in Patients with Refractory Rheumatoid Arthritis Published in Drugs in Context

Retrieved on: 
Monday, March 28, 2022
Nonsteroidal anti-inflammatory drug, Rheumatoid arthritis, Recursive definition, Population, Emergency, Enterprise master patient index, Osteoporosis, VAS, GCS, SJC, Adrenocorticotropic hormone, EMR, TJC, Surface Pro 2, Prescription, Food, Pain, LLC, Safety, Inflammation, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pharmacy, MCID, Physician, DMARD, Indian Rheumatology Association, Glucocorticoid, FDA, Weight gain, Uncertainty, Disease, Pros, Pharmaceutical industry, Health insurance, Patient, CDAI, Mallinckrodt

DUBLIN, March 28, 2022 /PRNewswire/ --  Mallinckrodt plc, (OTCMKTS: MNKKQ) a global biopharmaceutical company, today announced the publication of findings from a retrospective medical records study assessing the real-world utilization and outcomes of Acthar® Gel (repository corticotropin injection) in patients with refractory rheumatoid arthritis (RA) that did not adequately respond to standard-of-care therapies. The results of the study were published in the peer-reviewed journal Drugs in Context.

Key Points: 
  • The study, titled "Real-world Treatmenft Patterns for Repository Corticotropin Injection in Patients With Rheumatoid Arthritis," was a descriptive, noninterventional, U.S.-based, retrospective analysis of electronic medical records (EMRs) of 63 patients with refractory RA.
  • Most patients (74.6 percent) were using the recommended Acthar Gel dose of 80 units twice per week for 10.36.8 months.
  • "Our findings describe the potential benefits treatment with Acthar Gel may provide to patients with refractory, persistently active RA that is more difficult to treat."
  • "We are encouraged by the results of this study that help support the safety and effectiveness of Acthar Gel for short-term adjunctive treatment of refractory RA."